The long-term goal of MX-MAP is to develop a functional pipeline for the immune characterization of new 2D nanomaterials of MXene family, for the qualitative and quantitative assessment of the human immune compatibility and immune activity towards biomedical applications. MX-MAP will develop key chemistry and immune-based strategies for MXene medical applications.
The implication of this project extends beyond the specific nanoscience program greatly advancing the engineering process of 2D materials and their use in biomedicine. The MX-MAP project involves fourteen key players in European and non-European countries, including the United States, Canada, Saudi Arabia, and three partners from Ukraine, coming from academia and SMEs.
Chemistry, biology, immunology, engineering, and cancer research are the expertise of MX-MAP. The project Coordinator Dr. Lucia Gemma Delogu, University of Padua, Italy/NYU Abu Dhabi, UAE. The senior team members are among the most influential scientists, including Prof. Yury Gogotsi - inventor of MXenes, Prof. Klaus Ley - one of the most cited immunologists worldwide, and Prof. Husam N Alshareef.